Growth Metrics

AtriCure (ATRC) Debt to Equity (2016 - 2025)

AtriCure (ATRC) has disclosed Debt to Equity for 16 consecutive years, with $0.13 as the latest value for Q4 2025.

  • On a quarterly basis, Debt to Equity fell 10.36% to $0.13 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.13, a 10.36% decrease, with the full-year FY2025 number at $0.13, down 10.36% from a year prior.
  • Debt to Equity was $0.13 for Q4 2025 at AtriCure, down from $0.13 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.14 in Q4 2024 to a low of $0.09 in Q3 2023.
  • A 5-year average of $0.13 and a median of $0.13 in 2022 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: plummeted 51.62% in 2021, then soared 46.07% in 2024.
  • AtriCure's Debt to Equity stood at $0.12 in 2021, then increased by 10.46% to $0.14 in 2022, then decreased by 0.73% to $0.14 in 2023, then increased by 3.6% to $0.14 in 2024, then decreased by 10.36% to $0.13 in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Debt to Equity are $0.13 (Q4 2025), $0.13 (Q3 2025), and $0.13 (Q2 2025).